Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 15:372:577957.
doi: 10.1016/j.jneuroim.2022.577957. Epub 2022 Aug 29.

Genetics of neurosarcoidosis

Affiliations
Review

Genetics of neurosarcoidosis

Abigail Hardin et al. J Neuroimmunol. .

Abstract

Sarcoidosis is a systemic, inflammatory, granulomatous disease characterized by great variability in organ involvement, clinical course, and severity. While pulmonary manifestations are almost universal, the central and peripheral nervous systems can also be affected. Neurosarcoidosis occurs in ∼5-15% of cases and is among the manifestations with the highest morbidity and mortality. It is known that sarcoidosis has genetic underpinnings and while multiple studies aimed at identifying associations to sarcoidosis susceptibility and prognosis, very few studies have focused on neurosarcoidosis. This review summarizes the genetic studies to date, compares and contrasts those findings with other genetic effects in sarcoidosis, and offers ideas for moving the field forward.

Keywords: Genetic association; HLA-DRB1; Neurosarcoidosis; Zinc-Finger proteins.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Figure 1.
Figure 1.
Potential roles of ZNF592 in sarcoidosis and neurosarcoidosis.
Figure 2.
Figure 2.
Manhattan Plot of GWAS of neurosarcoidosis. The red line indicates genome-wide significance (p<5 × 10−8) and the blue line is suggestive significance (p<1 × 10−5). The blue circles correspond to regions containing F5, RP11–462L8.1, and AMN1 on Chromosomes 1, 10, and 12, respectively, and the red circle corresponds to the 15q25 region containing ZNF592.
Figure 3.
Figure 3.
Clustering of organ involvement in 242 European American (Panel A) and 900 African American (Panel B) sarcoidosis patients. Sample coordinates represent the first two MCA principal dimensions (Dim1 and Dim2). The proportion of the variance explained by each principal dimension is given in parentheses as a percentage. The colors and shapes represent cluster membership for the various organs involved. The clusters including neurological involvement are highlighted (green circle) and labeled. The primary, distinguishing organ systems in each of the other clusters are as follows: Panel A, 1-muscle and joint, 2-skin, 3-neurological and ocular, 4-renal, 5-cardiac, 6-liver and spleen; Panel B, 1-extra-thoracic lymph nodes, 2-skin, 3-eye, 4-neurological, 5-renal and cardiac, 6-liver and spleen, 7-muscle.

References

    1. ACCESS Research Group 1999. Design of a case-control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. Journal of Clinical Epidemiology, 52, 1173–1186. - PubMed
    1. ADRIANTO I, LIN CP, HALE JJ, LEVIN AM, DATTA I, PARKER R, ADLER A, KELLY JA, KAUFMAN KM, LESSARD CJ, MOSER KL, KIMBERLY RP, HARLEY JB, IANNUZZI MC, RYBICKI BA & MONTGOMERY CG 2012. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One, 7, e43907. - PMC - PubMed
    1. BAUGHMAN RP, FIELD S, COSTABEL U, CRYSTAL RG, CULVER DA, DRENT M, JUDSON MA & WOLFF G 2016. Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc, 13, 1244–52. - PubMed
    1. BAUGHMAN RP, TEIRSTEIN AS, JUDSON MA, ROSSMAN MD, YEAGER H JR., BRESNITZ EA, DEPALO L, HUNNINGHAKE G, IANNUZZI MC, JOHNS CJ, MCLENNAN G, MOLLER DR, NEWMAN LS, RABIN DL, ROSE C, RYBICKI B, WEINBERGER SE, TERRIN ML, KNATTERUD GL, CHERNIAK R & CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS RESEARCH, G. 2001. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med, 164, 1885–9. - PubMed
    1. BEN-OMRAN T, FAHIMINIYA S, SORFAZLIAN N, ALMURIEKHI M, NAWAZ Z, NADAF J, KHADIJA KA, ZAINEDDIN S, KAMEL H, MAJEWSKI J & TROPEPE V 2015. Nonsense mutation in the WDR73 gene is associated with Galloway-Mowat syndrome. J Med Genet, 52, 381–90. - PubMed

Publication types

Supplementary concepts